当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Genome editing to 're-write' wrongs
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-06-22 , DOI: 10.1038/nrd.2018.91 Mary Ellen Perry , Kayla M. Valdes , Elizabeth Wilder , Christopher P. Austin , Philip J. Brooks
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-06-22 , DOI: 10.1038/nrd.2018.91 Mary Ellen Perry , Kayla M. Valdes , Elizabeth Wilder , Christopher P. Austin , Philip J. Brooks
Genome editing to 're-write' wrongs
中文翻译:
基因组编辑以“重写”错误
基因组编辑以“重写”错误
更新日期:2018-06-22
Genome editing to 're-write' wrongs, Published online: 22 June 2018; doi:10.1038/nrd.2018.91
The NIH has launched the Somatic Cell Genome Editing (SCGE) programme to accelerate the development of safer and more effective genome-editing therapeutics.中文翻译:
基因组编辑以“重写”错误
基因组编辑以“重写”错误
基因组编辑以``重写''错误,在线发布:2018年6月22日; doi:10.1038 / nrd.2018.91
NIH已启动了体细胞基因组编辑(SCGE)计划,以加速开发更安全,更有效的基因组编辑疗法。